Advances in Combination Therapy for Asthma and COPD

Front Cover
Jan Lotvall
John Wiley & Sons, Nov 28, 2011 - Medical - 352 pages
Aimed at specialists in respiratory medicine, this new book comprehensively reviews the variety of agents currently available for treatment of asthma, COPD, and other airway diseases and covers practical guidelines as well as challenges and complications in their use. Advances in Combination Therapy for Asthma and COPD is the first book to address the complexity of multi-agent therapy and deal with management issues in an integrated fashion. A review of currently available agents and their applications, as well as new therapies soon to become available are outlined. Advantages of combined therapies and additional considerations that arise from multi-agent programs are highlighted.

What people are saying - Write a review

We haven't found any reviews in the usual places.


References 13
clinical effects in asthma and COPD 38
46 Printer Name Yet to Come
pharmacology mechanisms and interaction
Long and ultralongacting 2agonists 81
The safety of longacting betaagonists and the development
Novel antiinflammatory treatments for asthma and COPD 154
Novel biologicals alone and in combination
Antiinfective treatments in asthma and COPD 232
References 260
Longacting muscarinic antagonists in asthma and COPD 268
Phosphodiesterase inhibitors in obstructive lung disease 296
Biological therapies in development for COPD 311
inhaled steroid

Acknowledgement 128
Inhaled combination therapy with glucocorticoids

Other editions - View all

Common terms and phrases

About the author (2011)

Jan Lötvall, Professor, Head of Department, EAACI, Secretary-General, co-Editor-in-Chief Respiratory Research, Department of Respiratory Medicine and Allergology, Göteborg University, Göteborg, SWEDEN

Bibliographic information